The number of people with susceptibility test result for rifampicin in Bosnia and Herzegovina
Bosnia and Herzegovina: The number of people with susceptibility test result for rifampicin was 97.7 in 2021. ▲ Rising
Latest (2021)
97.7
Change on year
up 0.0%
World rank
38th
of 146 countries
All-time high
97.7
in 2021
All-time low
87.79
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Bosnia and Herzegovina, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Bosnia and Herzegovina stood at 97.7. That is the highest value across all 5 years on record.
The figure is up 11.3% over five years.
That places Bosnia and Herzegovina 38th out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Bosnia and Herzegovina, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 87.79 | — |
| 2018 | 97.32 | +10.9% |
| 2019 | 95.92 | -1.4% |
| 2020 | 97.65 | +1.8% |
| 2021 | 97.7 | +0.0% |
Bosnia and Herzegovina compared with similar countries
- Bosnia and Herzegovina's 97.7 is above the median for upper middle income countries, which is 92.7, 1.1× the median. (45 countries reporting)
- Bosnia and Herzegovina's 97.7 is above the median for Europe & Central Asia, which is 93.52, 1.0× the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 93.68 | 87.79 | 97.32 | 3 |
| 2020s | 97.68 | 97.65 | 97.7 | 2 |
Countries ranked near Bosnia and Herzegovina
More health data for Bosnia and Herzegovina
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.071 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,689 deaths per 1,000 people (2090)
- Number of infants who die before age 1 11 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.62 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.019 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.62 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Bosnia and Herzegovina?
- The number of people with susceptibility test result for rifampicin in Bosnia and Herzegovina was 97.7 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Bosnia and Herzegovina?
- The highest recorded value was 97.7 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Bosnia and Herzegovina?
- The lowest recorded value was 87.79 in 2017.
- How does Bosnia and Herzegovina rank for the number of people with susceptibility test result for rifampicin?
- Bosnia and Herzegovina ranks 38th out of 146 countries with data for 2021.
- Where does this Bosnia and Herzegovina data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).